THUMB_1740-12_Silhouette Vertical Full Color.png
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2024 07:30 ET | Abeona Therapeutics Inc.
CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity...
biodexa-logo-square (1).png
Receipt of Nasdaq Delisting Determination - Plans to Appeal
August 30, 2024 16:30 ET | Biodexa Pharmaceuticals PLC
August 30, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Receipt of Nasdaq Delisting Determination Plans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused...
Applied Digital - Logo - Horizontal - Black.png
Applied Digital Issues $53.2 Million Convertible Preferred Stock to Advance HPC Data Center Project and Accelerate Growth
August 30, 2024 16:05 ET | Applied Digital Corporation
DALLAS, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of next-generation digital infrastructure...
ARCA Logo - JPEG.jpg
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
August 29, 2024 16:50 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 29, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced completion of the merger with Oruka Therapeutics, Inc. (“Oruka”) following ARCA’s...
Pending Home Sales: July 2024
Pending Home Sales Dropped 5.5% in July
August 29, 2024 10:00 ET | National Association of Realtors®
WASHINGTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Key Highlights Pending home sales fell 5.5% in July.Month over month, contract signings declined in all four U.S. regions.Compared to one year ago,...
GeoVax_logo_hi-res-white-background-400x400.png
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
August 28, 2024 20:59 ET | GeoVax, Inc.
ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
2023_new_kraneshares_logo.png
KraneShares Launches AI-Powered China A-Share ETF (KCAI)
August 28, 2024 08:30 ET | KraneShares
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Krane Funds Advisors (“KraneShares”), an asset management firm known for its global exchange-traded funds (ETFs), today announced the launch of the...
Biora-tm_rgb.jpg
Biora Therapeutics Announces Positive Nasdaq Listing Decision
August 28, 2024 08:00 ET | Biora Therapeutics, Inc.
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that the company has been granted an...
Versus Logo.png
Versus Systems Receives NASDAQ Notification Regarding Minimum Stockholders’ Equity Deficiency
August 27, 2024 17:43 ET | Versus Systems Inc.
VANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Versus Systems, Inc. (NASDAQ: VS) (the “Company”) announces that it has received a letter from the listing qualifications department...
Picture1.png
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
August 27, 2024 16:30 ET | Eagle Pharmaceuticals, Inc.
WOODCLIFF LAKE, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company” or “Eagle”) today announced that it received a notice (the “Notice”) on August 21,...